|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Center for Complementary and Alternative Medicine (NCCAM) |
|---|---|
| Collaborator: |
Office of Dietary Supplements (ODS) |
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00066144 |
Purpose
This Phase II study, a follow-up to a Phase I trial in normal volunteers, will determine the efficacy of black cohosh and red clover for the relief of menopausal symptoms. It will also assess the safety of chronic dosing (1 year) by evaluating uterine (endometrial biopsies), breast (mammography), and hematology parameters (CBC and chemistry lab values) at baseline and 1 year.
| Condition | Intervention | Phase |
|---|---|---|
|
Hot Flashes Menopause |
Drug: Cimicifuga racemosa Drug: Trifolium pratense Drug: Black cohosh Drug: Red clover |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | Black Cohosh and Red Clover Efficacy for the Relief of Menopausal Symptoms |
Eligibility| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Illinois | |
| University of Illinois at Chicago | |
| Chicago, Illinois, United States, 60612 | |
| Principal Investigator: | Stacie Geller, MD | Department of Obstetrics and Gynecology University of Illinois, Chicago |
More Information
| Study ID Numbers: | P50 AT000155 |
| Study First Received: | August 4, 2003 |
| Last Updated: | October 11, 2007 |
| ClinicalTrials.gov Identifier: | NCT00066144 History of Changes |
| Health Authority: | United States: Federal Government |
|
menopause hot flashes red clover black cohosh sexual dysfunction |
|
Signs and Symptoms Hot Flashes |